These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 16980018
1. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation. Park JW, Lee KW, Kim SJ, Choi SH, Heo JS, Kwon CH, Kim DJ, Han YS, Lee SK, Joh JW. Transplant Proc; 2006 Sep; 38(7):2121-2. PubMed ID: 16980018 [Abstract] [Full Text] [Related]
2. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S. Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001 [Abstract] [Full Text] [Related]
3. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA. Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [Abstract] [Full Text] [Related]
4. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M. Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [Abstract] [Full Text] [Related]
5. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G. Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224 [Abstract] [Full Text] [Related]
6. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT. Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158 [Abstract] [Full Text] [Related]
7. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA. Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113 [Abstract] [Full Text] [Related]
8. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK. Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152 [Abstract] [Full Text] [Related]
9. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Hu RH, Ho MC, Wu YM, Yu SC, Lee PH. Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552 [Abstract] [Full Text] [Related]
10. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW. Clin Transplant; 2007 Apr; 21(6):696-701. PubMed ID: 17988261 [Abstract] [Full Text] [Related]
11. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545 [Abstract] [Full Text] [Related]
12. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. Lee HH, Joh JW, Park JH, Lee KW, Heo JS, Choi SH, Kim SJ, Lee SK. Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686 [Abstract] [Full Text] [Related]
13. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Kornberg A, Küpper B, Tannapfel A, Katenkamp K, Thrum K, Habrecht O, Wilberg J. Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941 [Abstract] [Full Text] [Related]
14. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539 [Abstract] [Full Text] [Related]
16. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? Saborido BP, Díaz JC, de Los Galanes SJ, Segurola CL, de Usera MA, Garrido MD, Elola-Olaso AM, Sánz RG, Romero CJ, Garcia García I, González EM. Transplant Proc; 2005 Nov; 37(9):3874-7. PubMed ID: 16386569 [Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH. Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620 [Abstract] [Full Text] [Related]
18. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases]. Chen GH, Yang Y, Lu MQ, Cai CJ, He XS, Zhu XF, Xu C, Li H, Huang JF. Zhonghua Wai Ke Za Zhi; 2004 Apr 07; 42(7):413-6. PubMed ID: 15144669 [Abstract] [Full Text] [Related]
19. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience. Castroagudín JF, Molina E, Bustamante M, Tomé S, Otero E, Martínez J, Segade FR, Conde R, Varo E. Transplant Proc; 2008 Nov 07; 40(9):2975-7. PubMed ID: 19010164 [Abstract] [Full Text] [Related]
20. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR. Cardiovasc Intervent Radiol; 2007 Nov 07; 30(5):888-93. PubMed ID: 17619218 [Abstract] [Full Text] [Related] Page: [Next] [New Search]